Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8247
Reference
MSAN(2024)48
Name
Methylphenidate prolonged-release tablets
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Methylphenidate prolonged-release tablet brands are in limited supply and intermittent regional supply disruptions are expected to continue until October 2024.
Lisdexamfetamine (Elvanse®, Elvanse Adult®) capsules remain available and can support increased demand.
Prescribed Elvanse® and Elvanse Adult® capsules generically until normal methylphenidate prolonged release tablet supply resumes.
Methylphenidate (Equasym® XL) modified-release capsules remain available but cannot support increased demand.
Unlicensed supplies of methylphenidate prolonged-release tablets can be sourced, lead times vary.
Contact Name
Contact Email
Contact Address
Created
2024-08-23 09:15:00
Click to go back to homepage